burgdorferi are also important in prevention ofB. burgdorferi infection, in that passive transfer of immune sera or protective monoclonal antibodies prevents the spirochete from establishing infection. It has previously been suggested that complement is necessary for effective antibody-mediated host responses against B. burgdorferi.
To investigate the role of complement in the pathogenesis and prevention of Lyme disease, we compared the responses to B. burgdorferi challenge inoculation of mice genetically deficient in the fifth component of complement (C5) with those of C5-sufficient mice. All C5-deficient strains tested were susceptible to B. burgdorferi infection, and disease manifestations underwent regression in a similar time-course to those of complement-sufficient mice. Moreover, passive immunization of C5-deficient mice with either immune rabbit sera or neutralizing monoclonal antibody protected them from challenge infection. These results demonstrate that the expression of Lyme disease is not altered in mice deficient in C5 and that C5-mediated complement activation is not necessary for antibody-mediated protection from infection.
Lyme disease (LD) is a multisystem disorder caused by the tick-borne spirochete Borrelia burgdorferi (14, 20, 21) . In humans, infection with B. burgdorferi may result in skin rash, arthritis, carditis, and neurologic abnormalities. We have previously described a model for LD in immunocompetent mice which shares many of the clinical and histologic features of human LD (1, 3, 5, 6) . All strains of mice are susceptible to B. burgdorferi infection, although disease severity varies among genotypes (1, 3, 5, 6) . As in human LD, mice infected with B. burgdorferi develop acute arthritis and carditis that undergo spontaneous resolution despite persistence of infection. The specific components of host immunity that contribute to disease manifestations and their resolution are poorly understood. Experiments in severe combined immunodeficient (SCID) mice, which lack both T and B cells, have shown that disease manifestations occur despite these immune abnormalities, indicating that neither T cells nor B cells are necessary for development of disease (6, 19) . In the SCID mouse, however, arthritis and carditis persist, suggesting that specific T-and/or B-cell immunity is required for disease regression.
The humoral immune response to B. burgdorferi is important in prevention of infection. Both passive transfer of immune sera to naive mice and active immunization of mice with B. burgdorferi prevent infection after challenge inoculation with B. burgdorferi (8, 18, 19 (17) . Although the epitopes recognized by these MAbs may be different, the fact that the protective MAb bears an IgG isotype capable of activating complement has led to speculation that complement may be necessary for antibodymediated protection (17) . This notion is supported by in vitro studies (12) suggesting that the bactericidal effect of B. burgdorferi-specific antibody is due to antibody-mediated complement activation. More recently, however, it has been proposed that the role of specific antibody is to increase the efficiency of the lytic activity of the C5b-9 membrane attack complex on B. burgdorferi (13) .
The present study was designed to evaluate whether deficiency in C5-dependent complement activation affects the natural course of LD in mice or the ability of specific antibody to protect mice from B. burgdorferi challenge inoculation. The results reported herein demonstrate that both disease regression and protective immunity against Lyme disease in mice do not require complement activities dependent upon C5.
MATERIALS AND METHODS
Mice. Three-week-old mice were purchased from Jackson Laboratory, Bar Harbor, Maine. The following strains of C5-deficient mice were used: A/J, AKR/J, B10.D2/oSnJ, DBA/2J, and SWR/J. C5 sufficiency or deficiency was determined by the vendor by using a sensitive hemolytic test measuring the ability of mouse sera to promote antibodymediated lysis of sheep erythrocytes (11, 15) . C5-sufficient control strains included B10.D2/nSnJ (congeneic with in paraffin and examined microscopically for evidence of disease. Arthritis severity was scored on a scale of 0 (no disease) to 3 (severe disease) as previously described (10) .
RESULTS AND DISCUSSION
To determine the effect of C5 deficiency on the pathogenesis of Lyme disease in mice, we compared the outcomes of B. burgdorferi challenge inoculation of several C5-deficient strains of mice with that of C5-sufficient mice. We have previously demonstrated that B. burgdorferi infection of C3H mice, a C5-sufficient strain, results in arthritis and carditis that peak between 2 and 4 weeks of infection and then undergo spontaneous regression that is complete by 90 days (1, 3, 5, 6 ). All C5-deficient strains tested were susceptible to B. burgdorfen infection and disease, although the severity of disease manifestations varied among genotypes, a finding consistent with disease in complement-sufficient strains (Table 1) . Similarly, arthritis (and carditis) underwent regression in the absence of C5, with fewer affected mice, fewer affected joints, and lower severity indices at 12 weeks compared with the 2-and 4-week time points (Table 1 ). All joints that were still positive at 12 weeks had features of resolution.
To determine whether biologic effects of complement activation involving C5 are necessary for antibody-mediated protection against infection, C5-sufficient and C5-deficient mice were passively immunized prior to challenge inoculation ( These results support the notion that activation of C5-dependent complement pathways is not necessary for either regression of LD manifestations, which may be dependent upon specific antibody, or for antibody-mediated resistance to B. burgdorfen infection in the mouse. Our studies utilized mice in which complement activity was deficient because of genetic defects resulting in the absence of C5. This essentially eliminates the concern that residual low levels of complement activity may be present, as might occur after complement depletion with cobra venom factor (22, 23) . Moreover, it is unlikely that residual rabbit complement in the rabbit immune sera, which was heat-inactivated prior to use, could have been responsible for antibody-mediated protection because the protective MAb, which was generated in complement-free medium, also conferred resistance to B. burgdorferi infection. Two strains of mice (DBA and B10.D2) were used in passive immunization studies. The C5-sufficient DBA/1J mouse differs from its C5-deficient counterpart DBAI2J at chromosome 3 (13) . On the basis of these observations, we favor the view that antibodies mediate bactericidal activity by both complement-independent and complement-dependent pathways, with the latter mechanism serving to enhance the former.
In summary, the results reported herein represent the first detailed analysis of the effect of CS deficiency on the course of LD and on passive transfer of resistance to B. burgdorfen infection in mice. Our results confirm that antibody-mediated bactericidal activity can occur in the absence of CSdependent complement activation. Further studies are in progress to better define the mechanisms by which specific antibody mediates B. burgdorfen killing.
